Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz, Giovanni Marsicano, Rafaël Maldonado, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 12, pp. 705-718
Open Access | Times Cited: 422

Showing 1-25 of 422 citing articles:

Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran, Tom P. Freeman, Claire Mokrysz, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 5, pp. 293-306
Open Access | Times Cited: 360
Inhibition in the amygdala anxiety circuitry
Olga Babaev, Carolina Piletti Chatain, Dilja Krueger‐Burg
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 4, pp. 1-16
Open Access | Times Cited: 256
Synaptic functions of endocannabinoid signaling in health and disease
Alfonso Araque, Pablo E. Castillo, Olivier J. Manzoni, et al.
Neuropharmacology (2017) Vol. 124, pp. 13-24
Open Access | Times Cited: 204
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior
C. Shen, Di Zheng, Kexin Li, et al.
Nature Medicine (2019) Vol. 25, Iss. 2, pp. 337-349
Closed Access | Times Cited: 191
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Elliot D. Mock, Berend Gagestein, Mario van der Stelt
Progress in Lipid Research (2022) Vol. 89, pp. 101194-101194
Open Access | Times Cited: 83
Fear of AI: an inquiry into the adoption of autonomous cars in spite of fear, and a theoretical framework for the study of artificial intelligence technology acceptance
Federico Cugurullo, Ransford A. Acheampong
AI & Society (2023) Vol. 39, Iss. 4, pp. 1569-1584
Open Access | Times Cited: 55
Overwriting an instinct: Visual cortex instructs learning to suppress fear responses
Sara Mederos, Pennelope Blakely, Nicole Vissers, et al.
Science (2025) Vol. 387, Iss. 6734, pp. 682-688
Open Access | Times Cited: 2
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia Suraev, Nathaniel S. Marshall, Ryan G. Vandrey, et al.
Sleep Medicine Reviews (2020) Vol. 53, pp. 101339-101339
Closed Access | Times Cited: 134
The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Eric W. Bow, John M. Rimoldi
Perspectives in Medicinal Chemistry (2016) Vol. 8
Open Access | Times Cited: 133
Anxiety and Brain Mitochondria: A Bidirectional Crosstalk
Michaela D. Filiou, Carmen Sandi
Trends in Neurosciences (2019) Vol. 42, Iss. 9, pp. 573-588
Open Access | Times Cited: 123
The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties
Owen Y. Chao, Maria A. de Souza Silva, Yi Yang, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 373-407
Open Access | Times Cited: 118
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Gaurav Bedse, Rebecca J. Bluett, Toni A. Patrick, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Role of the endocannabinoid system in drug addiction
Jorge Manzanares, David Cabañero, Nagore Puente, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 108-121
Open Access | Times Cited: 103
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 102
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 102
Polyunsaturated fatty acids and endocannabinoids in health and disease
Hércules Rezende Freitas, Alinny Rosendo Isaac, Renato Malcher‐Lopes, et al.
Nutritional Neuroscience (2017) Vol. 21, Iss. 10, pp. 695-714
Closed Access | Times Cited: 100
A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction
Laura Domingo‐Rodriguez, Iñigo Ruı́z de Azúa, Eduardo Dominguez, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Cathrin Rohleder, Juliane Müller, Bettina Lange, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 91
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 25
Open Access | Times Cited: 91
Localization of the cannabinoid type‐1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus
Ana Gutiérrez‐Rodrίguez, Itziar Bonilla Del Rio, Nagore Puente, et al.
Glia (2018) Vol. 66, Iss. 7, pp. 1417-1431
Open Access | Times Cited: 90
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
Rainer Spanagel
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 241-250
Open Access | Times Cited: 89
Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening
David J. Marcus, Gaurav Bedse, Andrew D. Gaulden, et al.
Neuron (2020) Vol. 105, Iss. 6, pp. 1062-1076.e6
Open Access | Times Cited: 85
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top